Markets calmed somewhat Tuesday, and Kenny Polcari, chief market strategist at SlateStone Wealth, believes the worst of the equity sell-off is over.
"There's a lot of damage done to some of these stocks and they're going to need to rebalance.
You need health care, you need consumer staples, you need energy.
So yes, I think there are opportunities certainly in the health care space that are good dividend payers as well," he said.
While the stock is not a "big sexy tech name," it is a "solid, great drug name," according to Polcari.